References
- Jacqz-Aigrain E, Leroux S, Zhao W, et al. How to use vancomycin optimally in neonates: remaining questions. Expert Rev Clin Pharmacol. 2015;8(5):635–648.
- Zou L, Meng F, Hu L, et al. A novel reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of imipenem and meropenem in human plasma and its application in TDM. J Pharm Biomed Anal. 2019;169:142–150.
- Lawyer MC, Lawyer EZ. Linezolid and reversible myelosuppression. JAMA. 2001;286(16):1974.
- Gonzales RD, Schreckenberger PC, Graham MB, et al. Infections due to vancomycin-resistant enterococcus faecium resistant to linezolid. Lancet. 2001;357(9263):1179.
- Yano R, Nakamura T, Tsukamoto H, et al. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations. Ther Drug Monit. 2007;29(4):399–403.
- Bhattacharyya S, Darby RR, Raibagkar P, et al. Antibiotic-associated encephalopathy. Neurology. 2016;86(10):963–971.
- Bowers LD. Analytical goals in therapeutic drug monitoring. Clin Chem. 1998;44(2):375–380.
- Kang JS, Lee MH. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1–10.
- Kirkman AC. A review of bacteriological sensitivity tests and a capillary tube method for the determination of antibiotic levels in the body fluids. Cent Afr J Med. 1956;2:367–369.
- Jones GR. The role of EQA in harmonization in laboratory medicine – a global effort. Biochem Med (Zagreb). 2017;27:23–29.
- Yi X, Wang Y, Zhang T, et al. Commutability of possible external quality assessment materials for progesterone measurement. Clin Biochem. 2021;87:39–45.